Wall Street Analysts Think Legend Biotech (LEGN) Could Surge 135.16%: Read This Before Placing a Bet

Legend Biotech Corporation Sponsored ADR (LEGN) closed the last trading session at $33.96, gaining 3.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $79.86 indicates a 135.2% upside potential.The average comprises 19 short-term price targets ranging from a low of $55 to a high of $95, with a standard deviation of $11.93. While the lowest estimate indicates an increase of 62% fro ...